- Home
- STRO vs VELO Comparison
STRO vs VELO Comparison
Compare STRO & VELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- VELO
- Stock Information
- Founded
- STRO 2003
- VELO 2014
- Country
- STRO United States
- VELO United States
- Employees
- STRO N/A
- VELO N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- VELO Industrial Machinery/Components
- Sector
- STRO Health Care
- VELO Technology
- Exchange
- STRO Nasdaq
- VELO Nasdaq
- Market Cap
- STRO 94.9M
- VELO 102.9M
- IPO Year
- STRO 2018
- VELO N/A
- Fundamental
- Price
- STRO $0.89
- VELO $5.38
- Analyst Decision
- STRO Hold
- VELO Strong Buy
- Analyst Count
- STRO 7
- VELO 1
- Target Price
- STRO $1.97
- VELO $6.00
- AVG Volume (30 Days)
- STRO 782.2K
- VELO 512.6K
- Earning Date
- STRO 11-06-2025
- VELO 11-10-2025
- Dividend Yield
- STRO N/A
- VELO N/A
- EPS Growth
- STRO N/A
- VELO N/A
- EPS
- STRO N/A
- VELO N/A
- Revenue
- STRO $105,646,000.00
- VELO $49,158,000.00
- Revenue This Year
- STRO $65.48
- VELO $30.60
- Revenue Next Year
- STRO N/A
- VELO $57.71
- P/E Ratio
- STRO N/A
- VELO N/A
- Revenue Growth
- STRO N/A
- VELO 59.44
- 52 Week Low
- STRO $0.52
- VELO $1.43
- 52 Week High
- STRO $3.01
- VELO $28.50
- Technical
- Relative Strength Index (RSI)
- STRO 48.24
- VELO N/A
- Support Level
- STRO $0.81
- VELO N/A
- Resistance Level
- STRO $0.95
- VELO N/A
- Average True Range (ATR)
- STRO 0.08
- VELO 0.00
- MACD
- STRO -0.00
- VELO 0.00
- Stochastic Oscillator
- STRO 53.02
- VELO 0.00
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About VELO Velo3D Inc. Common stock
Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.